Facebook Linkedin RSS Twitter Youtube
Home 2023

Biogen

As Biopharma Giants Reshape the Field, Cognition Therapeutics Sees a Place for Its Alzheimer’s Drug
Drug Discovery

As Biopharma Giants Reshape the Field, Cognition Therapeutics Sees a Place for Its Alzheimer’s Drug

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly
Bioprocessing

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly

Biogen to Acquire Reata for $7.3B, Adding to Neuro Drug Portfolio
Drug Discovery

Biogen to Acquire Reata for $7.3B, Adding to Neuro Drug Portfolio

StockWatch: Layoffs Extend Biogen’s Stock Skid
Drug Discovery

StockWatch: Layoffs Extend Biogen’s Stock Skid

AI, Cell/Gene Therapy, Precision Medicine Drive Bullish Biotech Investment
Artificial Intelligence

AI, Cell/Gene Therapy, Precision Medicine Drive Bullish Biotech Investment

Beacon of Light: Retinal Gene Therapy Developer Launches with $120M
Drug Discovery

Beacon of Light: Retinal Gene Therapy Developer Launches with $120M

Lilly Subsidiary, Scribe Ink Up-to-$1.5B CRISPR-Based Neuro Collaboration
Genome Editing

Lilly Subsidiary, Scribe Ink Up-to-$1.5B CRISPR-Based Neuro Collaboration

Sangamo Eliminating 27% of U.S. Workforce, Refocusing Pipeline
Drug Discovery

Sangamo Eliminating 27% of U.S. Workforce, Refocusing Pipeline

StockWatch: FDA Panel Enables Accelerated OK for Biogen ALS Drug
News

StockWatch: FDA Panel Enables Accelerated OK for Biogen ALS Drug

Removing Senescent Cells May Slow, Halt, or Reverse Diseases of Aging
Drug Discovery

Removing Senescent Cells May Slow, Halt, or Reverse Diseases of Aging

123...21Page 2 of 21
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.